Reducing the economic burden in management of Guillain–Barre syndrome using modified plasmapheresis

BACKGROUND: Guillain–Barre syndrome (GBS) is an autoimmune acute inflammatory demyelinating polyneuropathy affecting the peripheral nervous system treated with high-dose immunoglobulin, physical therapy, or plasmapheresis. Immunoglobulins are expensive and even plasmapheresis might not be affordable...

Descripción completa

Detalles Bibliográficos
Autores principales: Iyer, Rekha Ramaswamy, Shah, Pragnesh Hasmukhlal, Roy, Sher Sankar K., Suri, Sushil Kumar Kundanlal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4993079/
https://www.ncbi.nlm.nih.gov/pubmed/27605847
http://dx.doi.org/10.4103/0973-6247.187940

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4993079/
https://www.ncbi.nlm.nih.gov/pubmed/27605847
http://dx.doi.org/10.4103/0973-6247.187940

Ejemplares similares